TOMS Capital Investment Management has amassed a stake in Kenvue Inc. and is pushing for changes at the consumer health company, which has only just avoided a battle with an activist investor.

Kenvue, which was spun out of Johnson & Johnson in 2023, had a market value of about $45 billion at close of trading in New York on Friday. A spokesperson for TOMS declined to comment.

March 23 (Reuters) - Investment firm TOMS Capital Investment Management has amassed a stake in the Band-Aid maker Kenvue (KVUE.N), opens new tab and is pushing the company to consider a full sale ...

Kenvue KVUE has been analyzed by 10 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table below ...

(Reuters) -Investment firm TOMS Capital Investment Management has amassed a stake in the Band-Aid maker Kenvue (NYSE:KVUE) and is pushing the company to consider a full sale or separation of some ...

TOMS Capital Investment has amassed a stake in Kenvue (KVUE) and is pushing for changes at the company, Crystal Tse of Bloomberg reports. TOMS is urging Kenvue to consider a full sale or ...

During an interview with NFL Network's The Insiders upon signing his new deal, Williams dished out some first impressions of the Patriots and his new head coach in Mike Vrabel, providing nothing ...

Investors in Kenvue Inc (Symbol: KVUE) saw new options begin trading this week, for the November 21st expiration. One of the key inputs that goes into the price an option buyer is willing to pay ...

Johnson & Johnson’s Kenvue – previously the planned New Consumer Health Company – is just one part of the 135-year old company’s plan to reinvigorate its corporate image. The name "Kenvue ...